logo

For the Inventor, By the Inventor

Wolhusen, Switzerland

Geistlich Pharma Ag


USPTO Granted Patents = 33



Trademarks = 19

Forward Citations = 132

Loading Chart...
Loading Chart...

26 inventors (with patents filed for the assignee):

goldMedal Rolf Wilhelm Pfirrmann (11 out of 47 patents)

silverMedal Michael Alexander Bufler (8 out of 8 patents)

bronzeMedal Lothar Schloesser (6 out of 14 patents)

4.  Claudio Zihlmann (5 out of 5 patents)

5.  Peter Geistlich (4 out of 27 patents)

6.  Daniel Suppiger (3 out of 3 patents)

7.  Paul Buxton (3 out of 3 patents)

8.  Nino Kurz (3 out of 3 patents)

9.  Niklaus Stiefel (3 out of 4 patents)

10.  Hanns Moehler (3 out of 3 patents)

11.  Thomas Mueller (3 out of 3 patents)

12.  Mark Spilker (2 out of 6 patents)

13.  Charles Zelen (2 out of 2 patents)

14.  David Armstrong (2 out of 2 patents)

15.  Paul Glat (2 out of 2 patents)


33 patents:

1. 12514847 - Oxathiazin_dioxide for treating, preventing, inhibiting or reducing cytokine release (2026-01-06),
2. 11999709 - Processes for preparing oxathiazin-like compounds (2024-06-04),
3. 11633519 - Dried implant composition and injectable aqueous implant formulation (2023-04-25),
4. 11591302 - Processes for preparing oxathiazin-like compounds (2023-02-28),
5. 11571494 - Method for treating subjects suffering from chronic ulcers (2023-02-07),
6. 11357891 - Collagen matrix or granulate blend of bone substitute material (2022-06-14),
7. 11351287 - Bone substitute material (2022-06-07),
8. 10968190 - Processes for preparing oxathiazin-like compounds (2021-04-06),
9. 10960107 - Collagen matrix or granulate blend of bone substitute material (2021-03-30),
10. 10918592 - Injectable aqueous implant formulation containing ascorbic acid (2021-02-16),
11. 10869949 - Method for treating subjects suffering from chronic ulcers (2020-12-22),
12. 10835640 - Resorbable crosslinked form stable membrane for use outside the oral cavity (2020-11-17),
13. 10736902 - Method of treating triple negative breast cancer (2020-08-11),
14. 10695461 - Dried implant composition and injectable aqueous implant formulation (2020-06-30),
15. 10646619 - Bone substitute material (2020-05-12),
Geistlich Pharma AG is a leading global provider of medical devices and pharmaceutical products for the healthcare sector. Established in 1851, the company specializes in regenerative medicine and offers innovative solutions for dental, orthopedic, and medical applications. With a strong focus on research and development, Geistlich Pharma AG continues to deliver high-quality products that contribute to patient well-being and improve the quality of life. Visit their website for more information.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

33 Patents

#1 in Wolhusen

#397 in Switzerland

#19,571 in the World

...
Wolhusen, Switzerland

Geistlich Pharma Ag

Forward Citations = 132

26 inventors:

goldMedal Rolf Wilhelm Pfirrmann (11 out of 47 patents)

silverMedal Michael Alexander Bufler (8 out of 8 patents)

bronzeMedal Lothar Schloesser (6 out of 14 patents)

4.  Claudio Zihlmann (5 out of 5 patents)

5.  Peter Geistlich (4 out of 27 patents)

Please report any incorrect information to support@idiyas.com
Loading…